A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Pharmacodynamics of Lemborexant in Korean Subjects With Insomnia Disorder

Eisai Clinical Trials

Protocol # E2006-J082-204

Study Overview

Study Compound: E2006

Drug Name: lemborexant

Registry #: NCT05594589

Trial Period: Nov 2022 - May 2024

Indication: Insomnia

Primary Endpoint: 1. Change From Baseline of LPS on Day 30 of LEM10 Treatment Compared to PBO [Time Frame: Baseline, Day 30]

2. Change From Baseline of Objective Sleep Efficiency (SE) on Day 30 of LEM5 Treatment Compared to PBO [Time Frame: Baseline, Day 30]

Population
Males and females 19 Years to 80 Years (Adult, Older Adult)
Study Status
Completed
Study Phase
Phase 2
Countries
Korea, Republic of

Results

CSR Synopsis

No download available

Lay Summary

Download PDF

Publication reference citation

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

CSDR Sharing is not available for this study.

CSDR	Availability
Clinical Trial Data

Redacted documents may be available upon request for this study.

Document type	Availability
Protocol
SAP
Sample CRF
Full CSR